Discontinued — last reported Q3 '25

Other Income & Expense

Other Income (Expense)

Bristol-Myers Squibb Other Income (Expense) increased by 121.9% to $108.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 146.2%, from -$234.00M to $108.00M.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ3 2025Oct 30, 2025

How to read this metric

An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.

Detailed definition

Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...

Peer comparison

Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.

Metric ID: other_income_expense_net

Historical Data

16 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$2.00M$409.00M-$649.00M-$284.00M$140.00M$413.00M$116.00M$258.00M$371.00M-$81.00M-$273.00M-$234.00M-$305.00M-$339.00M-$494.00M$108.00M
QoQ Change>999%-258.7%+56.2%+149.3%+195.0%-71.9%+122.4%+43.8%-121.8%-237.0%+14.3%-30.3%-11.1%-45.7%+121.9%
YoY Change<-999%-65.8%+163.6%+140.8%+84.3%-119.6%-335.3%-190.7%-182.2%-318.5%-81.0%+146.2%
Range-$649.00M$413.00M
CAGR+189.7%
Avg YoY Growth<-999%
Median YoY Growth-100.3%

Frequently Asked Questions

What is Bristol-Myers Squibb's other income (expense)?
Bristol-Myers Squibb (BMY) reported other income (expense) of $108.00M in Q3 2025.
How has Bristol-Myers Squibb's other income (expense) changed year-over-year?
Bristol-Myers Squibb's other income (expense) increased by 146.2% year-over-year, from -$234.00M to $108.00M.
What does other income (expense) mean?
The net result of all income and expenses not related to core business operations.